Press release: London, UK – July 22, 2025 – Corinthia Global Management (“Corinthia”) announces its role as lead lender on debt facilities to support Ampersand Capital Partners’ (“Ampersand”) acquisition of CurTec, a Netherlands-based manufacturer of high-performance packaging for the pharmaceutical, specialty chemicals, and food ingredients industries.
The financing provided by Corinthia will support CurTec’s continued growth and international expansion. The company is known for its focus on product quality, regulatory compliance, and sustainability, serving customers in highly regulated end-markets.
This recent transaction is consistent with Corinthia’s strategic emphasis on targeting opportunities within the core middle market, specifically companies with EBITDAs ranging from US$10 million to US$100 million. Over the years, the team has established strong and trustworthy relationships with the private equity and advisor community in the European and US middle market.
Benjamin Gillet, Managing Director, European Investments at Corinthia Global Management, commented:
“We are pleased to support Ampersand in the acquisition of CurTec. CurTec is a well-established business with a clear position in regulated packaging and a strong reputation in its field. We see meaningful potential in the company’s growth plans and value Ampersand’s disciplined, sector-focused investment approach. This is a good fit with our strategy of providing capital to support long-term value creation.”
The Corinthia deal team included Christel Huguet, Philip Ashley and Benjamin Gillet.
-END-
About Corinthia Global Management
Corinthia Global Management Limited is a leading, technology-enabled private credit platform operating across Europe, America, and Asia Pacific regions to originate and manage global private credit investment opportunities for its investment partners worldwide. The platform delivers scale and a world class team to drive market leading returns in the growing subsector of core mid-market private credit. For further information about Corinthia Global Management Limited, visit www.corinthiagm.com.
About Ampersand Capital Partners
Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, and Amsterdam, The Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm’s core healthcare sectors.
For additional information, visit https://ampersandcapital.com or follow us on LinkedIn.
About CurTec
CurTec designs, manufactures, and supplies high-performance plastic packaging for companies in the pharmaceutical, specialty chemicals, and food ingredients industries. Headquartered in Rijen, the Netherlands, CurTec operates in a GMP-certified, ISO 9001 and ISO 14001 environment and focuses on providing clean, safe, and sustainable packaging solutions for demanding applications.